Reuters logo
BRIEF-OHR Pharmaceutical takes actions to suspend activities at San Diego lab facility
February 22, 2017 / 11:10 PM / in 10 months

BRIEF-OHR Pharmaceutical takes actions to suspend activities at San Diego lab facility

Feb 22 (Reuters) - OHR Pharmaceutical Inc:

* OHR Pharmaceutical- on Feb. 21, 2017, co took actions to suspend activities at its lab facility in San Diego, California- SEC filing

* OHR Pharmaceutical- suspension of preclinical activities at lab facility will result in reduction in workforce of about 8 positions at lab facility

* OHR Pharmaceutical Inc - reduction in workforce of approximately 8 positions at lab facility, reduction will occur immediately Source text: (bit.ly/2m9fC7K) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below